Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.42
+0.07 (0.84%)
At close: Jun 18, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 18.78 billion as of June 18, 2026. Its market cap has decreased by -34.44% in one year.
Market Cap
18.78B
Enterprise Value
19.36B
Revenue
4.41B
Ranking
n/a
PE Ratio
32.19
Stock Price
8.42
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 18.78B, a decrease of -15.94%. That is a compound annual growth rate of -4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 18.78B | -16.96% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Zhifei Biological Products | 29.23B |
| Beijing Tiantan Biological Products | 24.34B |
| Hebei Changshan Biochemical Pharmaceutical | 23.76B |
| Suzhou Zelgen Biopharmaceuticals | 23.74B |
| Hualan Biological Engineering | 23.46B |
| Xiamen Amoytop Biotech | 22.79B |
| BrightGene Bio-Medical Technology | 18.81B |
| Sinocelltech Group | 16.07B |